NFKB1 and Insulin resistance: Accordingly, recent studies reported that genetic disruption of key inflammatory pathways in the hypothalamus, such as TLR4/MyD88 or IKKb/NF-kB pathways, is protective against the metabolic complications induced by HFD including hypothalamic insulin resistance (64, 66, 67).